ORCHIDECTOMY VALUE IN THE TREATMENT OF OESTROGEN-RESISTANT PROSTATIC NEOPLASMS Article published in Urologia Polska 1985/38/2.
authors
-
Leszek Jaromin, Janina Szymańska, Marek Rożniecki
- Z Kliniki Urologii Instytutu Chirurgii AM w Łodzi Kierownik Kliniki: doc. dr hab. med. L. Jeromin
summary
- The authors report their observations from a period of ten years concerning the treatment of oestrogen-resistant prostatic neoplasma in 31 patients in whom orchidectomy was done decause of deteriorating general condition and urinary retention. In 25 cases the patients improved, and in 7 cases spontaneous bladder voiding became again possible. ,In 24 cases transurethral prostatic electroresection was re±uired. Secondary orchidectomy improved the general condition of most patients but had no effect on the progression of prostatic tumour.
references
- 1. Blackard C. E., Doe R. P., Mellinger G. T., Byar D. P.: Incidens of cardio-
- vascular disease and death in patients reaceiving diethylstilbestiol for carcinoma
- of the prostatae. Cancer, 1970, ,26, 249. ? 2. Blacklock N. J.: Prostatic cancer. Urol.
- Res., 1977, 5, 1. ? 3. Ghisholm G. D., O'Donoghue E. P. N., Kennedy C. L.. The
- treatment of oestrogen-escaped carcinoma of the (prostate with estramustine phos
- phate. Brit. J. Urol., 1977, 49, 717. ? 4. Davies C, Jacobi J., Lloyd H. M., Meares
- J. D.: DNA synthesis and the secretion of Prolactin and growth hormone by the
- pituitary gland of the male rat: effects of diethylsilboestrol and 2-bromo-alfa-ergo-
- cniptine rnethanesulphonate. J. Endocr., 1974, 61, 411. ? 5. Fossa S. D., Fossa J.,
- Aakvaag A.: Hormone changes in patients with prostatic carcinoma during treat
- ment with estramustine phosphate. J. Urol., 1977, 118, 1913. ? 6. Hachmeister U.:
- Hyperplasia of Prolactin cells after estrogen therapy in carcinoma of the prostate.
- Verh. Dt. Ges. Path., 1972, 56, 535. ? 7. Ishibe T.: Effect of long term estrogen
- treatment on liver function in patients with prostatic carcinoma. J. Urol., 1975,
- 1.13, 829. ? 8. Ishibe T., Usui T., Nihira H.: Prostatic value of liver function tests
- in carcinoma of the prostate. Urol. Int., 1976, 31, 205. ? 9. luman W. H. W., Ves-
- sey M. P., Westerholm B., Engelund A.: Tromboembolic disease and the steroidol
- content of oral contraceptive:s. A report to the Committee on Safety of Drugs. Brit.
- Med. J., 1970, 2, 203. ? 10. Jacobi G. H, Altwein J. E.: Bromocriptine, ein neues
- thearapeutische Rrioziip ibeSim Postate-Adeinom und Karaimom. Dt. med. Wschr.,
- 1978, 103, 827.
- 11I. Jeromin L.: Testosteronie and Prolactin levels in the serum patients with
- carcinoma of the prostatae treated verious doses of fostrolin and bromocriptin.
- Int. Urol. Nephrol., 19:82, 14, 51. ? 12. Jeromin L., Prelich A.: Własne do¶wiadcze
- nia w leczeniu estracytem estrogeno-opornych nowotworów stercza. Urol. Pol.,
- 1982, 3?4, 209. ? 13. Jeromin L.: Znaczenie prolaktyny we wzro¶cie nowotworów
- stercza. Pol. Tyg. Dek., 1980, 35, 453. ? 14. Jeromin L.: Zastosowanie bromokryp
- tyny w leczeniu raka stercza. Urol. Pol., 1982, 3?4, 141. ? 15. Jeromin L.: Meta
- bolizm testosteronu w raku stercza. Urol. Pol., 1982, 3?4, 135. ? 16. Mazurek L:
- Ksi±żka pod redakcj± Zieliński J.: Onkologia Urologiczna. PZWL, Warszawa, 1977. ?
- 17. Resnick M. I., Grayhack J. T: Effect of 2-bromo-alfa-ergocriptine (CB-154) on
- estrogen induced growth of the rat prostate. Invest. Urol., 1978, 15, 392. ? 18. Sau-
- ford E. J., Paulson D. F., Rohner T.J., Drago J. R., Sauten R. J., Bardini C. W.:
- The effects of castration on adrenal testosterone secretion in men with prostatic
- carcinoma. J. Urol., 1977, 118, 1019. ? 19. Straube W., Braun J. S.: Zur Orchidekto
- mie und Oestrogentherapie des Prostatakarzinams. Urologe A., 1974, 13, 198. ? 20.
- The Veterans Administration Cooperative Urological Research Group: Treatment
- and survival of patients with cancer of the prostate. Surg. Gynec. Obstet., 1967,
- 124, 1011.
|